Cognitive impairment and cortisol levels in first-episode schizophrenia patients

References

• Aas M, Mondelli V, Toulopoulou T, Reichenberg A, Di Forti M, Fisher H. (2011). Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis. Psychol Med 41:463–76.
   PubMed Web of Science ®Google Scholar
• Addington J, Addington D. (2002). Cognitive functioning in first-episode schizophrenia. J Psychiatry Neurosci 27:188–92.
   PubMed Web of Science ®Google Scholar
• Bilder R, Goldman RS, Robinson D, Reiter G, Bell L, Bates JA, Pappadopulos E, et al. (2000). Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am J Psychiatry 157:549–59.
   PubMed Web of Science ®Google Scholar
• Borges S, Gayer-Anderson C, Mondelli V. (2013). A systematic review of the activity of hypothalamic-pituitary-adrenal axis in first episode psychosis. Psychoneuroendocrinology 38:603–11.
   PubMed Web of Science ®Google Scholar
• Bradley AJ, Dinan TG. (2010). A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality. J Psychopharmacol (Oxford) 24:91–118.
   PubMed Web of Science ®Google Scholar
• Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, James NM, et al. (1981). A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Arch Gen Psychiatry 38:15–22.
   PubMed Web of Science ®Google Scholar
• Ceskova E, Kasparek T, Zourkova A, Prikryl R. (2006). Dexamethasone suppression test in first episode schizophrenia. Neuro Endocrinol Lett 27:433–7.
   PubMed Web of Science ®Google Scholar
• Cohrs S, Roher C, Jordan W, Meier A, Huether G, Wuttke W, Rüther E, Rodenbeck A. (2006). The atypical antipsychotics, olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects. Psychopharmacology 185:11–18.
   PubMed Web of Science ®Google Scholar
• Corcoran CM, Walker E, Huot R, Mittal V, Tessner K, Kestler L, Malaspina D. (2003). The stress cascade and schizophrenia: etiology and onset. Schizophr Bull 29:671–92.
   PubMed Web of Science ®Google Scholar
• Corcoran CM, Smith C, McLaughlin D, Auther A, Malaspina D, Cornblatt B. (2012). HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia. Schizophr Res 135:170–4.
   PubMed Web of Science ®Google Scholar
• Garner B, Phassouliotis C, Phillips LJ, Markulev C, Butselaar F, Bendall S, Yun Y, McGorry PD. (2011). Cortisol and dehydroepiandrosterone-sulphate levels correlate with symptom severity in first-episode psychosis. J Psych Res 45:249–55.
   Web of Science ®Google Scholar
• Harvey PD, Keefe RSE. (2009). Clinical neuropsychology of schizophrenia. In: Grant I, Adams KM, editors. Neuropsychological assessment of neuropsychiatric and neuromedical disorders. Oxford: Oxford University Press. p 507–22.
   Google Scholar
• Horan WP, Ventura J, Nuechterlein KH, Subotnik KL, Hwang SS, Mintz J. (2005). Stressful life events in recent-onset schizophrenia: reduced frequencies and altered subjective appraisals. Schizophr Res 75:33–374.
   Web of Science ®Google Scholar
• Lee BK, Glass TA, McAtee MJ, Wand GS, Bandeen-Roche K, Bolla KI, Schwartz BS. (2007). Associations of salivary cortisol with cognitive function in the Baltimore memory study. Arch Gen Psychiatry 64:810–18.
   PubMed Web of Science ®Google Scholar
• Lupien SJ, Fiocco A, Wan Maheu F, Lord C, Schramek T, Tu MT. (2005). Stress hormones and human memory function across the lifespan. Psychoneuroendocrinology 30:225–42.
   PubMed Web of Science ®Google Scholar
• Lupien SJ, Maheu F, Fiocco A, Schramek TE. (2007). The effects of stress and stress hormones on human cognition: implications for the field of brain and cognition. Brain Cogn 5:209–37.
   Web of Science ®Google Scholar
• McAllister-Williams RH, Rugg MD. (2002). Effects of repeated cortisol administration on brain potential correlates of episodic memory retrieval. Psychopharmacology 160:74–83.
   PubMed Web of Science ®Google Scholar
• Mittal VA, Walker EF. (2011). Minor physical anomalies and vulnerability in prodromal youth. Schizophr Res 129:116–21.
   PubMed Web of Science ®Google Scholar
• Montalvo I, Creus M, Solé M, Feliu T, Franch J, Vilella E, Gutiérrez-Zotes A, Labad J. (2013). Sex differences in the relationship between cortisol awakening response and working memory in subjects with early psychosis [Abstract]. Eur Neuropsychopharmacol 23:439–40.
   Google Scholar
• Newcomer JW, Hershey T, Bardgett ME, Csernansky JG, Craft S, Gagliardi AE, Vogler G. (1998). Glucocorticoid interactions with memory function in schizophrenia. Psychoneuroendocrinology 23:65–72.
   PubMed Web of Science ®Google Scholar
• Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. (2004). Identification of separable cognitive factors in schizophrenia. Schizophr Res 72:29–39.
   PubMed Web of Science ®Google Scholar
• Phillips LJ, McGorry PD, Garner B, Thompson KN, Pantelis C, Wood SJ, Berger G. (2006). Stress, the hippocampus and the hypothalamic–pituitary–adrenal axis: implications for the development of psychotic disorders. Aust N Z J Psychiatry 40:725–41.
   PubMed Web of Science ®Google Scholar
• Read J, van Os J, Morrison AP, Ross CA. (2005). Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications. Acta Psychiatr Scand 112:330–50.
   PubMed Web of Science ®Google Scholar
• Reichenberg A, Harvey PD. (2007). Neuropsychological impairments in schizophrenia: integration of performance-based and brain imaging findings. Psychol Bull 133:833–58.
   PubMed Web of Science ®Google Scholar
• Ritsner MS, Strous RD. (2010). Neurocognitive deficits in schizophrenia are associated with alterations in blood levels of neurosteroids: a multiple regression analysis of findings from a double-blind, randomized, placebo-controlled, crossover trial with DHEA. J Psychiatr Res 44:75–80.
   PubMed Web of Science ®Google Scholar
• Townsend LA, Malla KA, Norman RM. (2000). Cognitive functioning in stabilized first-episode psychosis patients. Psychiatry Res 104:119–31.
   Web of Science ®Google Scholar
• Tuma I, Lenderova Z. (2001). Schizofrenie a kognitivní funkce. Psychiatrie 4:275–82.
   Google Scholar
• Walder DJ, Walker EF, Lewine RJ. (2000). Cognitive functioning, cortisol release, and symptom severity in patients with schizophrenia. Biol Psychiatry 48:1121–32.
   PubMed Web of Science ®Google Scholar
• Walker E, Mittal V, Tessner K. (2008). Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu Rev Clin Psychol 4:189–216.
   PubMed Web of Science ®Google Scholar
• Wolf OT. (2003). HPA axis and memory. Best Pract Res Clin Endocrinol Metab 2:287–99.
   Web of Science ®Google Scholar
• Zhang JP, Gallego JA, Robinson DG, Malhotra AK, Kane JM, Corell CU. (2013). Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. Int J Neuropssychopharmacol 16:1205–18.
   PubMed Web of Science ®Google Scholar